Literature DB >> 11533152

Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants.

A S Lauring1, M M Anderson, J Overbaugh.   

Abstract

Cytopathic, T-cell-tropic feline leukemia viruses (FeLV-T) evolve from FeLV-A in infected animals and demonstrate host cell specificities that are distinct from those of their parent viruses. We recently identified two cellular proteins, FeLIX and Pit1, required for productive infection by these immunodeficiency-inducing FeLV-T variants (M. M. Anderson, A. S. Lauring, C. C. Burns, and J. Overbaugh, Science 287:1828-1830, 2000). FeLV-T is the first example of a naturally occurring type C retrovirus that requires two proteins to gain entry into target cells. FeLIX is an endogenous protein that is highly related to the N-terminal portion of the FeLV envelope protein, which includes the receptor-binding domain. Pit1 is a multiple-transmembrane phosphate transport protein that also functions as a receptor for FeLV-B. The FeLV-B envelope gene is derived by recombination with endogenous FeLV-like sequences, and its product can functionally substitute for FeLIX in facilitating entry through the Pit1 receptor. In the present study, we tested other retrovirus envelope surface units (SUs) with their cognate receptors to determine whether they also could mediate infection by FeLV-T. Cells were engineered to coexpress the transmembrane form of the envelope proteins and their cognate receptors, or SU protein was added as a soluble protein to cells expressing the receptor. Of the FeLV, murine leukemia virus, and gibbon ape leukemia virus envelopes tested, we found that only those with receptor-binding domains derived from endogenous FeLV could render cells permissive for FeLV-T. We also found that there is a strong preference for Pit1 as the transmembrane receptor. Specifically, FeLV-B SUs could efficiently mediate infection of cells expressing the Pit1 receptor but could only inefficiently mediate infection of cells expressing the Pit2 receptor, even though these SUs are able to bind to Pit2. Expression analysis of feline Pit1 and FeLIX suggests that FeLIX is likely the primary determinant of FeLV-T tropism. These results are discussed in terms of current models for retrovirus entry and the interrelationship among FeLV variants that evolve in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533152      PMCID: PMC114457          DOI: 10.1128/JVI.75.19.8888-8898.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments.

Authors:  D Lavillette; A Ruggieri; S J Russell; F L Cosset
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.

Authors:  S Boomer; M Eiden; C C Burns; J Overbaugh
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  I-mf, a novel myogenic repressor, interacts with members of the MyoD family.

Authors:  C M Chen; N Kraut; M Groudine; H Weintraub
Journal:  Cell       Date:  1996-09-06       Impact factor: 41.582

4.  Functional dissection of the Moloney murine leukemia virus envelope protein gp70.

Authors:  Y Bae; S M Kingsman; A J Kingsman
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 5.  Enveloped viruses: a common mode of membrane fusion?.

Authors:  F M Hughson
Journal:  Curr Biol       Date:  1997-09-01       Impact factor: 10.834

6.  Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.

Authors:  C S Tailor; D Kabat
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.

Authors:  S R Gwynn; F C Hankenson; A S Lauring; J L Rohn; J Overbaugh
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Analysis of FeLV-FAIDS provirus burden and productive infection in lymphocyte subsets in vivo.

Authors:  S L Quackenbush; G A Dean; J I Mullins; E A Hoover
Journal:  Virology       Date:  1996-09-01       Impact factor: 3.616

9.  GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus.

Authors:  S V Johann; J J Gibbons; B O'Hara
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  Substitution of a single amino acid residue is sufficient to allow the human amphotropic murine leukemia virus receptor to also function as a gibbon ape leukemia virus receptor.

Authors:  M V Eiden; K B Farrell; C A Wilson
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more
  25 in total

Review 1.  Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

Authors:  J Overbaugh; A D Miller; M V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2001-09       Impact factor: 11.056

2.  Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domain.

Authors:  Peggy Ho Faix; Steven A Feldman; Julie Overbaugh; Maribeth V Eiden
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variants.

Authors:  Heather H Cheng; Maria M Anderson; F Claire Hankenson; Lily Johnston; Chitra V Kotwaliwale; Julie Overbaugh
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Identification of a retroviral receptor used by an envelope protein derived by peptide library screening.

Authors:  Anindita Sarangi; Keith Bupp; Monica J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-20       Impact factor: 11.205

Review 5.  Studies of endogenous retroviruses reveal a continuing evolutionary saga.

Authors:  Jonathan P Stoye
Journal:  Nat Rev Microbiol       Date:  2012-05-08       Impact factor: 60.633

6.  Feline leukemia virus T entry is dependent on both expression levels and specific interactions between cofactor and receptor.

Authors:  Heather H Cheng; Maria M Anderson; Julie Overbaugh
Journal:  Virology       Date:  2006-10-13       Impact factor: 3.616

7.  Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.

Authors:  M M Anderson; A S Lauring; S Robertson; C Dirks; J Overbaugh
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.

Authors:  Michaela Rodenburg; Meike Fischer; Afra Engelmann; Stephanie O Harbers; Marion Ziegler; Jürgen Löhler; Carol Stocking
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 9.  Advances in understanding molecular determinants in FeLV pathology.

Authors:  Laura S Levy
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

10.  A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A.

Authors:  Ramon Mendoza; Maria M Anderson; Julie Overbaugh
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.